Literature DB >> 7091047

The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior.

P Häyry, J J Reitamo, S Tötterman, D Hopfner-Hallikainen, A Sivula.   

Abstract

Eighty histologically verified cases of the desmoid tumor (DT) have been analyzed with regard to factors possibly contributing to the etiology and/or growth behavior of this uncommon neoplasm. Considering the four statistical age components, the "fertile" female and "menopausal" varieties of the DT grew distinctly faster (0.1 less than P greater than 0.05 and less than 0.05), and the female "juvenile" variety distinctly slower (0.1 less than P greater than 0.05) than the male DTs. In a visual estimate, the fertile female patients had a significant (P less than 0.01) predisposition to estrogen predominance, while fewer patients than expected displayed progesterone predominance or were at balance (P = NS and less than 0.01, respectively). Thirty-two per cent of the patients with an abdominal DT had been previously operated in the region of subsequent tumor growth. Significantly more pregnancies were observed in patients with abdominal DT than with extra-abdominal DT (P less than 0.05). On only one occasion did sigmoideoscopy reveal colonic polyposis (Gardner's syndrome). The most striking observation was, however, that up to 80% of the affected patients (compared with less than 5% in the normal control population, P less than 0.05) had multiple minor bone anomalies demonstrable by x-ray screening of the mandible, chest, and long bones. We suggest that a generalized (inherited or mutant) defect in growth regulation of connective tissue is the most important underlying cause for the DT. However, the other factors, including hormonal effects, trauma, and pregnancy contribute to the growth behavior of the tumor.

Entities:  

Mesh:

Year:  1982        PMID: 7091047     DOI: 10.1093/ajcp/77.6.674

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  30 in total

1.  Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes.

Authors:  R Houlston; M Crabtree; R Phillips; M Crabtree; I Tomlinson
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

2.  Extra-abdominal fibromatosis (desmoid tumor) arising in the infratemporal fossa: a case report.

Authors:  M Corsten; P Donald; J Boggan; A Gadre; R Gandour-Edwards; W Nemzek
Journal:  Skull Base Surg       Date:  1998

3.  Pregnancy does not increase the local recurrence rate after surgical resection of desmoid-type fibromatosis.

Authors:  Justin M M Cates
Journal:  Int J Clin Oncol       Date:  2014-08-16       Impact factor: 3.402

4.  Development and rapid growth of a desmoid tumor in the surgical corridor after suboccipital craniotomy for recurrent low-grade astrocytoma.

Authors:  Todd McCall; Ganesh Rao; Randy Jensen
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

5.  Gigantic recurrent abdominal desmoid tumour: a case report.

Authors:  E A Rakha; M A Kandil; M G El-Santawe
Journal:  Hernia       Date:  2006-12-06       Impact factor: 4.739

6.  Case report 253. Gardner syndrome with aggressive fibromatosis.

Authors:  W Bessler; B Egloff; H Sulser
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

Review 7.  Current ideas in desmoid tumours.

Authors:  N Julian H Sturt; Susan K Clark
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

8.  Abscess formation in desmoid tumors of Gardner's syndrome and percutaneous drainage: a report of three cases.

Authors:  C Maldjian; H Mitty; A Garten; W Forman
Journal:  Cardiovasc Intervent Radiol       Date:  1995 May-Jun       Impact factor: 2.740

9.  [Extra-abdominal desmoid tumors. Case report and literature review].

Authors:  J Ridders; A Ernst; I Todt; R O Seidl
Journal:  HNO       Date:  2005-07       Impact factor: 1.284

Review 10.  Desmoid tumour in familial adenomatous polyposis. A review of literature.

Authors:  A L Knudsen; S Bülow
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.